Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Authors:
- Jin WanJWJin Wan
- Jiankun LiuJLJiankun Liu
- Wei XieWXWei Xie
- Xinwei DiaoXDXinwei Diao
- Jianping XuJXJianping Xu
- Bo ZhuBZBo Zhu
- Zhengtang ChenZCZhengtang Chen
- 1 September 2010
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 69 (3) , 348-354
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Tumor-derived lymphangiogenic factors and lymphatic metastasisBiomedicine & Pharmacotherapy, 2007
- IL-17 Family Cytokines and the Expanding Diversity of Effector T Cell LineagesAnnual Review of Immunology, 2007
- VEGF-C–induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sitesBlood, 2006
- Tumor lymphangiogenesis and metastatic spread—New players begin to emergeInternational Journal of Cancer, 2006
- Lymphangiogenesis Correlates with Lymph Node Metastasis, Prognosis, and Angiogenic Phenotype in Human Non–Small Cell Lung CancerClinical Cancer Research, 2005
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17Nature Immunology, 2005
- Interleukin-17 Family Members and InflammationImmunity, 2004
- Complex and controversial issues in locally advanced non-small cell lung carcinomaSeminars in Surgical Oncology, 2003
- Prognostic Factors in Non-small Cell Lung CancerChest, 2002
- Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptorImmunity, 1995